Major Progress Towards Commercialisation of FerriScan™
1. TGA Listing for Australia
2. Provides reciprocal access to Europe through CE Mark
3. US FDA 510(k) to be submitted before end of 2004
4. Major radiology partner identified for initial Australian
commercial roll-out, commencing December 2004
5. First commercial sales achieved via Novartis contract
